EMA — authorised 24 October 2019
- Marketing authorisation holder: ASTELLAS PHARMA EUROPE BV
- Status: approved
🇪🇺 Xospata in European Union
EMA authorised Xospata on 24 October 2019
Marketing authorisation
Xospata in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Xospata approved in European Union?
Yes. EMA authorised it on 24 October 2019.
Who is the marketing authorisation holder for Xospata in European Union?
ASTELLAS PHARMA EUROPE BV holds the EU marketing authorisation.